CytoTronics
Pixel Systems for Cell Biology Discovery
- Business Model
- B2B
- Website
- cytotronics.com
- Total Funding
- $22.8M
- Last Round
- $13.5M SeedSep 2024
- Rounds
- 2
About
Semiconductor-based high-throughput platforms providing live cell insights on viability, morphology, and electrophysiology at scale.
Summary
CytoTronics is a Biotech company. It has raised $22.8M in total across 2 rounds, most recently a $13.5M Seed round in Sep 2024. Investors include Anzu Partners, LYFE Capital and Draper Associates.
Tech & App Stack
6 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Sep 2024
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...